Related Experiment Videos

Paediatric Baha

Ann-Louise McDermott, Patrick Sheehan

    Advances in Oto-Rhino-Laryngology
    |March 11, 2011
    PubMed

    Insights

    Bone-anchored hearing aids (Baha) offer effective aural rehabilitation for children, improving hearing and quality of life. Careful patient selection and a multidisciplinary approach ensure successful outcomes with rare serious complications.

    Area of Science:

    • Otolaryngology
    • Pediatric Audiology
    • Biomedical Engineering

    Background:

    • Bone-anchored hearing aids (Baha) are a recognized solution for pediatric hearing loss.
    • Evidence supports Baha's efficacy in improving audiological outcomes and quality of life in children.
    • There's a global rise in pediatric Baha service centers.

    Purpose of the Study:

    • To review the current status of Baha for pediatric aural rehabilitation.
    • To discuss evolving indications and surgical considerations for pediatric Baha.
    • To highlight challenges and best practices in managing children with Baha.

    Main Methods:

    • Literature review of Baha in pediatric populations.
    • Analysis of audiological and quality of life outcomes.
    • Discussion of surgical techniques, timing, and complication rates.

    Main Results:

    • Baha demonstrates significant benefits for children's hearing and quality of life.
    • Pediatric Baha presents unique challenges including complex medical and social factors.
    • Surgical techniques and timing vary, but serious complications remain rare.

    Conclusions:

    • Baha is a valuable tool for pediatric hearing rehabilitation.
    • Addressing pediatric-specific challenges is crucial for successful Baha implantation.
    • Careful patient selection and a multidisciplinary team are key to optimal outcomes.

    Related Concept Videos

    Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

    Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

    Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
    Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

    Pharmacokinetics in Pediatric Patients: Drug Distribution

    Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
    Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

    Pharmacokinetics in Pediatric Patients: Drug Excretion

    In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
    Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

    Pharmacokinetics in Pediatric Patients: Drug Metabolism

    In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
    Drug Dosing: Infants and Children01:29

    Drug Dosing: Infants and Children

    Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
    Pedigree Analysis01:35

    Pedigree Analysis

    Overview